Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.667
Neutral
RSI(14)
41.462
Neutral
STOCH(KDJ)(9,3,3)
28.809
Sell
ATR(14)
4.980
High Vlolatility
CCI(14)
-20.672
Neutral
Williams %R
72.323
Sell
TRIX(12,20)
-0.164
Sell
StochRSI(14)
0.000
Oversold
Search
ICU Medical Inc
ICUIAdd to Watchlist
118.720USD
-4.270-3.47%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
2.97BMarket Cap
63.24P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of ICU Medical Inc
Currency: USD Updated: 2026-05-15Key Insights
ICU Medical Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 38 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 173.40.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ICU Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
ICU Medical Inc Highlights
StrengthsRisks
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 63.24, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 28.59M shares, increasing 2.18% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 337.74K shares of this stock.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
173.400
Target Price
+40.99%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of ICU Medical Inc is 5.99, ranking 174 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 530.23M, representing a year-over-year decrease of 12.32%, while its net profit experienced a year-over-year decrease of 294.70%.
Score
Financials
6.62
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.80
Operational Efficiency
7.47
Growth Potential
5.92
Shareholder Returns
7.14
ICU Medical Inc's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of ICU Medical Inc is 8.38, ranking 23 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 63.24, which is 8257.09% below the recent high of 5285.43 and 927.86% above the recent low of -523.58.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 38/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15The current earnings forecast score of ICU Medical Inc is 8.33, ranking 50 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 180.00, with a high of 200.00 and a low of 172.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
173.400
Target Price
+40.99%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
116
Total
6
Median
9
Average
Company name
Ratings
Analysts
ICU Medical Inc
ICUI
6
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of ICU Medical Inc is 6.89, ranking 78 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 129.82 and the support level at 110.49, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
122.332
Sell
MA10
121.643
Sell
MA20
122.463
Sell
MA50
125.468
Sell
MA100
137.490
Sell
MA200
133.435
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-15Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Janus Henderson Investors
Fuller & Thaler Asset Management Inc.
Dimensional Fund Advisors, L.P.
State Street Investment Management (US)
Schroder Investment Management North America Inc.
River Road Asset Management, LLC
1
2
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of ICU Medical Inc is 7.52, ranking 37 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.73
VaR
+3.58%
240-Day Maximum Drawdown
+27.18%
240-Day Volatility
+43.31%
Return
Best Daily Return
60 days
+4.87%
120 days
+5.96%
5 years
+26.23%
Worst Daily Return
60 days
-4.59%
120 days
-4.59%
5 years
-17.31%
Sharpe Ratio
60 days
-2.61
120 days
-0.49
5 years
-0.04
Risk Assessment
Maximum Drawdown
240 days
+27.18%
3 years
+55.51%
5 years
+68.82%
Return-to-Drawdown Ratio
240 days
-0.33
3 years
-0.19
5 years
-0.11
Skewness
240 days
-0.33
3 years
+0.50
5 years
+1.23
Volatility
Realised Volatility
240 days
+43.31%
5 years
+43.33%
Standardised True Range
240 days
+4.05%
5 years
+4.56%
Downside Risk-Adjusted Return
120 days
-86.41%
240 days
-86.41%
Maximum Daily Upside Volatility
60 days
+28.37%
Maximum Daily Downside Volatility
60 days
+30.67%
Liquidity
Average Turnover Rate
60 days
+1.19%
120 days
+1.09%
5 years
--
Turnover Deviation
20 days
+2.04%
60 days
+6.28%
120 days
-2.88%
Peer Comparison
Healthcare Equipment & Supplies
ICU Medical Inc
ICUI
7.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
